Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search


Second phase of vaccine clinical trials begins

24 October 2002 Media Statement

Second phase of Group B meningococcal vaccine clinical trials begins

Health Minister Annette King and the University of Auckland are pleased to announce the start of the second phase of clinical trials of a vaccine to fight group B meningococcal disease.

Ms King said the start of the new phase of clinical trials signified a big step toward combating the killer disease.

Clinical Trial Principal Investigator, Auckland University Professor Diana Lennon, said she was delighted. “Every step we take in this process brings us closer to significantly reducing the impact group B meningococcal disease is having on New Zealanders, and particularly children under five years old.

“Almost every day a child is admitted to hospital somewhere in New Zealand and the chances are these children will suffer long-term problems even if they survive this disease,” she said.

Ms King said last year 26 people of the 650 who contracted the disease died.

“Up to 20 percent of the other 624 would have been left with serious disability. Still more would have been left with educational or behavioural difficulties. Meningococcal disease has raged war in New Zealand at epidemic levels for 11 years now, and could easily continue to kill dozens and leave hundreds disabled every year for the next decade if we didn’t develop a vaccine,” she said.

“This disease affects New Zealanders from all walks of life, but the rate is particularly high amongst Pacific and Maori communities.

“The Government has committed significant resources, up to $200 million, to putting a stop to this dreadful disease as part of its wider commitment to improving child health and the health status of all New Zealanders.

“Immunisation is a simple, safe and effective way of protecting children from disease. Through vaccination we have been able to eliminate such serious diseases such as polio and diphtheria, and we are hoping that through the Meningococal Vaccine Strategy, group B meningococcal disease will join the list of diseases that we can use vaccination to fight,” Ms King said.

Phase I of the clinical trials involved 75 healthy adult volunteers. The first part of phase II involves about 300 eight to twelve-year-old children in the south Auckland suburbs of Manurewa and Papakura. The vaccine is similar to one that has been administered in more than 40 million doses overseas with no recorded unexpected serious adverse reactions.

The Ministry of Health, which manages the Meningococcal Vaccine Strategy, has contracted Auckland University to run the clinical trials. Auckland University is also responsible for evaluating the programme, in terms of vaccine effectiveness and epidemic control.

The vaccine was developed and is being manufactured by the Californian-based Chiron Corporation, in association with the Norwegian Institute of Public Health.


For background information on the Meningococcal Vaccine Strategy or meningococcal disease visit www.moh.govt.nz/meningococcal.

© Scoop Media

Parliament Headlines | Politics Headlines | Regional Headlines


Breed Laws Don’t Work: Vets On New National Dog Control Plan

It is pleasing therefore to see Louise Upston Associate Minister for Local Government calling for a comprehensive solution... However, relying on breed specific laws to manage dog aggression will not work. More>>


Corrections Corrected: Supreme Court Rules On Release Dates

Corrections has always followed the lawful rulings of the Court in its calculation of sentence release dates. On four previous occasions, the Court of Appeal had upheld Corrections’ practices in calculating pre-sentence detention. More>>


Not Waiting On Select Committee: Green Party Releases Medically-Assisted Dying Policy

“Adults with a terminal illness should have the right to choose a medically assisted death,” Green Party health spokesperson Kevin Hague said. “The Green Party does not support extending assisted dying to people who aren't terminally ill because we can’t be confident that this won't further marginalise the lives of people with disabilities." More>>


General Election Review: Changes To Electoral Act Introduced

More effective systems in polling places and earlier counting of advanced votes are on their way through proposed changes to our electoral laws, Justice Minister Amy Adams says. More>>

Gordon Campbell: On Our Posturing At The UN

In New York, Key basically took an old May 2 Washington Post article written by Barack Obama, recycled it back to the Americans, and still scored headlines here at home… We’ve had a double serving of this kind of comfort food. More>>


Treaty Settlements: Bills Delayed As NZ First Pulls Support

Ngāruahine, Te Atiawa and Taranaki are reeling today as they learnt that the third and final readings of each Iwi’s Historical Treaty Settlement Bills scheduled for this Friday, have been put in jeopardy by the actions of NZ First. More>>


Gordon Campbell: On The Damage De-Regulation Is Doing To Fisheries And Education, Plus Kate Tempest

Our faith in the benign workings of the market – and of the light-handed regulation that goes with it – has had a body count. Back in 1992, the free market friendly Health Safety and Employment Act gutted the labour inspectorate and turned forestry, mining and other workplace sites into death traps, long before the Pike River disaster. More>>

Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news